Inflammation and Fertility: The System Nobody Checked

Medical Disclaimer: This article is for educational purposes only and is not medical advice. Always consult your physician or qualified healthcare provider for medical decisions. Full disclaimer at the bottom of this page.

If you have been told your AMH is low and inflammation has never come up in that conversation, you are not alone. Most fertility workups do not check for it. The hsCRP, the homocysteine, the thyroid antibodies, the gut picture, and the food sensitivities are not standard in a reproductive endocrinology and infertility (REI) evaluation. And yet when we review cases at Fab Fertile where low AMH has not responded to conventional protocols, these are the systems that almost always tell the rest of the story.

The AMH number reflects how many follicles are currently being recruited. It says nothing about the biological environment those follicles are developing inside. Inflammation, when it is present and unaddressed, shapes that environment in ways that no stimulation protocol can compensate for.

That is the argument this article is built around. Not that AMH does not matter. That it has been treated as the whole story when it is only part of one.

Inflammation and fertility: what you need to know. Systemic inflammation, measurable through markers like high sensitivity C-reactive protein (hsCRP), homocysteine, antinuclear antibodies (ANA), and ferritin, can disrupt egg quality, implantation, hormone signaling, and thyroid function. These are standard blood draws available at most clinics and labs. They are rarely ordered as part of a fertility workup. Addressing the inflammatory picture they reveal has changed outcomes for women who were told their AMH number was the whole story.


[DEV: PODCAST EMBED: Get Pregnant Naturally episode on hsCRP and inflammation place within top 30% of page]

Why hsCRP and Inflammation Are Missed in Fertility Workups


What Inflammation Actually Does Inside the Body

Inflammation is not a condition. It is a biological response. When the immune system detects a threat from a gut infection, a food sensitivity, a toxin, chronic stress, or an autoimmune trigger it activates. Inflammatory signals circulate. And when that activation becomes chronic and low-grade rather than acute and resolved, those signals do not stay contained. They reach the ovaries, the follicles, the uterine environment, and the hormonal signaling pathways that govern the entire reproductive cycle.

The follicle does not develop in isolation. Over the approximately 90 days from early recruitment through ovulation, it is in continuous communication with the body's internal environment. Mitochondrial energy production, nutrient availability, hormonal signaling, immune activity, and oxidative stress load all shape what happens inside that follicle during those three months. When inflammatory load is elevated throughout that window, the follicle develops inside a compromised environment. No stimulation protocol changes that. No supplement regimen fully compensates for it if the underlying drivers have not been addressed.

This is why hsCRP, homocysteine, ANA, and ferritin matter in a fertility context. They are not exotic markers. They are standard blood draws that tell us whether the biological environment developing eggs are maturing inside is supporting that process or working against it. A ferritin level below the functional fertility target of 80 to 100 ng/mL signals that iron stores are insufficient to support optimal cellular function. An hsCRP above 1.0 mg/L signals that low-grade systemic inflammation is present. A homocysteine above 7.2 micromoles per liter (µmol/L) signals that methylation pathways are under strain, which affects both implantation and early pregnancy stability. None of these findings require a specialist referral to investigate. They require someone to order the tests.

How hsCRP and Inflammation Impact Fertility Outcomes

Implantation Failure: How Gut Health and Inflammation Affect Implantation


Five Patterns We Look For When Inflammation Is in the Picture

Inflammation is not a single thing. It enters through different biological doors, and each one shapes fertility in a different way. These are the five patterns we evaluate at Fab Fertile when a woman comes to us with unexplained poor outcomes, low AMH, or a fertility picture that has not responded to conventional protocols.


Pattern 1: Gut-Driven Immune Activation and Infections

The gut microbiome is one of the primary regulators of immune activity in the body. When the gut barrier is compromised from chronic stress, antibiotic use, hormonal contraception, or persistent infections inflammatory signals do not stay local. They circulate throughout the body and reach the reproductive system in ways that a standard fertility workup will never capture.

One mechanism worth understanding is the estrobolome the subset of gut bacteria responsible for metabolizing estrogens. When dysbiosis is present, estrogen reabsorption increases. That amplifies autoimmune activity and alters ovarian signaling directly. Another is the gut-thyroid axis: gut bacteria are responsible for converting a significant portion of inactive thyroid hormone T4 into active T3. When the microbiome is disrupted, thyroid function suffers downstream even when the thyroid gland itself is functioning normally.

One of the most consistent findings in our GI-MAP stool testing is an active infection that nobody has investigated. H. pylori is one of the most common it impairs stomach acid production, disrupts nutrient absorption, and drives systemic inflammation in ways that directly affect hormone metabolism and egg quality. Blastocystis hominis is another pattern we see regularly and one that conventional medicine frequently dismisses as clinically insignificant. In our clinical work it is consistently associated with chronic inflammation, immune activation, and gut barrier disruption that directly affects fertility outcomes. We also see Giardia, Cryptosporidium, parasitic infections broadly, Candida and fungal overgrowth, opportunistic bacterial overgrowth, and in some cases reactivated Epstein-Barr virus sitting underneath unexplained fertility challenges that have never been investigated.

This is a point worth stating directly: no amount of clean eating, supplement taking, or protocol adjusting will move the needle if an active infection is present and unaddressed. The infection is the upstream driver. It has to be found first. That is why GI-MAP stool testing DNA-based analysis of the full microbial picture including infections, dysbiosis, gut barrier markers, and immune indicators is a foundational step in every case review at Fab Fertile, not an optional add-on.

Gut Health, Low AMH, and High FSH

Gut Health and the Fertility Connection

Chronic Infections and Infertility

Constipation, Gut Health, and Fertility


Pattern 2: Thyroid Autoimmunity and Immune Dysregulation

Thyroid autoimmunity affects nearly 10% of women of reproductive age. A standard REI workup checks thyroid stimulating hormone (TSH). It does not routinely check antibodies. And yet thyroid peroxidase (TPO) antibody positivity is independently associated with lower implantation rates, poorer embryo quality, increased miscarriage risk, and lower ovarian reserve even when TSH is within the standard reference range.

The functional fertility TSH target we use at Fab Fertile is 0.5 to 2.0 mIU/mL. The standard lab reference range accepts values up to 4.5 mIU/mL as normal. That gap is where a significant number of women sit told their thyroid is fine while their reproductive outcomes continue to tell a different story. A full thyroid panel includes free T3, free T4, reverse T3, TPO antibodies, and thyroglobulin antibodies. Reverse T3 is particularly relevant because it reflects the body converting available thyroid hormone into an inactive form a stress-state adaptation that de-prioritizes reproduction. It does not appear on a standard TSH panel. And it is one of the most consistent findings we see in cases where low AMH is present alongside unexplained poor outcomes.

TPO antibodies have been detected in follicular fluid, meaning the autoimmune activity is not just systemic it is present in the immediate environment surrounding the developing egg. That is the mechanism behind why thyroid autoimmunity affects embryo quality even when hormone levels appear normal on paper.

Thyroid Health, Low AMH, DOR, and POI

Can Hypothyroidism Cause Infertility?

Hashimoto's and Premature Ovarian Insufficiency


Pattern 3: Food Sensitivity and Dietary Inflammation

Food sensitivity is not the same as food allergy. The reaction is delayed, sometimes by 48 to 72 hours, which means most women have no idea that what they ate two days ago is contributing to the low-grade inflammatory response showing up in their hsCRP today. Standard allergy testing does not capture delayed immune reactions. Food sensitivity is almost never investigated in a standard fertility workup despite being one of the most consistent and addressable contributors to systemic inflammation we see in case reviews.

Gluten is the most consistently relevant trigger we see in women with thyroid autoimmunity and fertility challenges. The molecular structure of gluten fragments is similar to thyroid tissue, which means ongoing gluten exposure can amplify autoimmune activity against the thyroid directly through a process called molecular mimicry. For anyone with elevated TPO antibodies or a known autoimmune history, gluten removal for 60 to 90 days alongside food sensitivity testing is non-negotiable in our protocol. This is a targeted elimination and systematic reintroduction process that identifies the specific triggers driving inflammation in that individual's body.

Dairy is evaluated through the same lens. We do not remove foods permanently without cause. We assess them systematically to identify whether they are contributing to the inflammatory picture, then make decisions based on what the testing and the clinical response actually show rather than applying a blanket dietary template to every person.

How Gluten Impacts Egg and Sperm Health

Eczema, Skin Conditions, and Pregnancy Success

Psoriasis, Skin Rashes, and Fertility


Pattern 4: Metabolic Inflammation

Insulin resistance and blood sugar dysregulation are among the most consistent and most overlooked drivers of chronic inflammation in women on the fertility journey. Elevated insulin triggers a systemic inflammatory response. Oxidative stress from unstable blood sugar damages the mitochondria within developing follicles the same mitochondria that determine whether an egg has the cellular energy to fertilize and develop into a viable embryo.

The markers we evaluate go beyond what a standard fertility workup orders. Fasting insulin alongside fasting glucose gives a more complete metabolic picture than fasting glucose alone a woman can have a normal fasting glucose and still have elevated fasting insulin that signals early insulin resistance. Hemoglobin A1c, triglycerides, and hsCRP are evaluated as an integrated picture of metabolic inflammatory burden rather than as isolated data points.

Homocysteine sits in this pattern too. Our functional target is 6.0 to 7.2 µmol/L. Elevated homocysteine is associated with implantation failure, miscarriage, and neural tube defects, and is commonly driven by B vitamin deficiencies particularly methylated B12 and folate that a standard prenatal panel will miss entirely. Vitamin D sits here as well. Our functional fertility target is 60 to 80 ng/mL. Research consistently associates low vitamin D with elevated inflammatory markers, lower AMH, and poorer embryo quality.

Addressing Homocysteine Levels for Egg and Sperm Health

The Clotting Connection: Hidden Causes of Implantation Failure


Pattern 5: Stress, Adrenal Dysregulation, and the HPA Axis

Chronic stress does not stay in the nervous system. When the body perceives ongoing threat whether from emotional stress, physical overtraining, blood sugar instability, gut infections, or the cumulative burden of trying to conceive for months or years the hypothalamic-pituitary-adrenal (HPA) axis activates. Cortisol rises. And the body makes a biological priority decision: survival over reproduction.

The mechanism is direct. Elevated cortisol suppresses the hypothalamic-pituitary-ovarian (HPO) axis, the signaling pathway that governs follicle recruitment, ovulation, and the hormonal cascade that supports conception. It also drives the conversion of active thyroid hormone T3 into reverse T3, an inactive form that blocks thyroid receptors and further de-prioritizes reproductive function. Reverse T3 does not appear on a standard TSH panel. It is not something a typical fertility workup orders. And it is one of the most consistent findings we see in women who present with low AMH, irregular cycles, and a stress history that spans years rather than months.

What makes this pattern particularly relevant on the fertility journey is that the journey itself becomes a source of chronic stress. The monitoring, the waiting, the failed cycles, the financial pressure all of it activates the same HPA axis response that was already present before treatment began. Addressing adrenal function is not optional support work. It is foundational to whether the other interventions in the protocol can actually work.

Sleep is where this pattern becomes most visible and most overlooked. Poor sleep is not just a symptom of stress it is a driver of it. Blood sugar crashes overnight spike cortisol, which disrupts progesterone production and compounds the adrenal dysregulation that is already present. Waking between 2 and 4 am, struggling to fall asleep despite exhaustion, dragging through the day after eight hours in bed these are not random inconveniences. They are biological signals that the HPA axis is dysregulated and the body is not recovering. Consistently disrupted sleep impairs hormone regulation, increases systemic inflammation, and directly compromises egg quality. Research from Fertility and Sterility confirms that optimal sleep of seven to eight hours improves IVF outcomes. We work on sleep hygiene as a clinical priority in the Fab Fertile Method, not as a lifestyle suggestion.

How Poor Sleep Could Be Sabotaging Your Egg Quality

Are You Getting Enough Sleep for Fertility?

Mood Swings, Sugar Cravings, Poor Sleep, and Fertility

Anxiety, Nervous System, and Reproductive Health

The Gut-Brain Connection and Infertility


Natalie's Story: Low AMH, hsCRP 1.3 mg/L, Natural Conception in Six Months

Natalie came to Fab Fertile with secondary infertility and a low AMH result. She had been told donor eggs might be her realistic next step. When we reviewed her full picture, her hsCRP was 1.3 mg/L mild but measurable systemic inflammation that her REI had never checked. Gut imbalances and hormone dysregulation were present alongside it. None of it had been connected to her fertility picture before she came to us.

Over six months following the Fab Fertile Method gut repair, targeted diet changes, stress regulation, and hormone optimization Natalie conceived naturally. The AMH number did not change what was possible. Addressing what was driving the biological environment around it did.

If your hsCRP has never been checked, your thyroid antibodies have never been tested, and your gut has never been evaluated, you have not yet had a complete picture. You have had a partial one.

Read Natalie's full story

 

If your AMH is low and your hsCRP has never been checked, your workup is incomplete.

Every cycle that proceeds without evaluating the inflammatory systems influencing follicle quality is a cycle running on incomplete information. Women who come to us after multiple failed cycles almost always have something in the inflammatory picture that was never addressed. That is not a coincidence. It is a gap in the standard evaluation model.

Book a Functional Fertility Second Opinion

Download the Embryo Audit Checklist

Why Most Plans Miss the Mark

You were told your AMH was low. But your hsCRP was never checked.


You were told your thyroid was normal. But a standard TSH test does not tell you whether thyroid hormone is being produced, converted, and used effectively or whether autoimmune activity is disrupting the process. A TSH of 3.5 mIU/mL is within the conventional normal range. It is not optimal for fertility. The functional target at Fab Fertile is 0.5 to 2.0 mIU/mL. Thyroid peroxidase antibody positivity is independently associated with implantation failure and miscarriage even when TSH is completely normal. If antibodies were never tested, the thyroid picture is incomplete.


You were told to take a prenatal vitamin so your nutrition is covered. But supplements cannot correct what the gut cannot absorb, and inflammation is one of the primary drivers of impaired gut barrier function. When the gut lining is compromised, nutrient absorption is disrupted. The same markers that support egg quality folate, B12, iron, zinc, magnesium, vitamin D are exactly the ones most affected by gut dysbiosis and inflammatory load. What we find consistently: women who have been supplementing for months with no movement in their deficiency markers, because the absorption problem driving the deficiency has never been addressed.


You were told stress might be a factor but to try to relax. But the adrenal picture is not about stress levels. It is about physiology. Chronic activation of the HPA axis elevates cortisol, drives the conversion of active T3 into reverse T3, and suppresses the reproductive signaling pathway that governs follicle recruitment and ovulation. That is not a mindset issue. It is a measurable hormonal pattern that shows up in testing and responds to targeted intervention. Telling someone to manage their stress without evaluating the adrenal picture is not a fertility strategy.


You were told the next cycle needs a different protocol. But the stimulation protocol operates on whatever biological environment is present when the cycle starts. If the inflammatory drivers have not been addressed, the gut has not been evaluated, the thyroid picture is incomplete, and the adrenal function has not been assessed, the next cycle proceeds with the same inputs as the last one. Changing the medication dose does not change the environment those eggs are developing inside. That is why the same pattern repeats across cycles even when the protocol changes.


For more on what a complete functional evaluation looks like when inflammation is in the picture, listen to our episode on hsCRP and the role of inflammation in diminished ovarian reserve, and our podcast on how gut health and inflammation affect implantation.

Why hsCRP Is Missed and Why It Matters

Implantation Failure: Gut Health and Inflammation


A Functional Fertility Audit: Inflammation and Immune Signaling

This is how we read the picture at Fab Fertile, compared to what a standard workup typically captures.


Area

Conventional View

Fab Fertile Pattern Interpretation

Systemic Inflammation (hsCRP, homocysteine, ANA, ferritin)

Not part of a standard fertility workup. Not considered fertility-relevant unless a known inflammatory disease is present.

hsCRP below 1.0 mg/L is the functional target. Homocysteine functional target 6.0 to 7.2 µmol/L. Ferritin functional target 80 to 100 ng/mL. Values outside these ranges signal low-grade chronic inflammation disrupting hormone signaling, mitochondrial function, and implantation. The pattern we consistently see: none of these markers have been checked. When they are, they explain outcomes that were attributed entirely to AMH.

Thyroid Function and Autoimmunity

TSH ordered if symptoms are present. Antibodies rarely checked. TSH within standard reference range considered normal.

Full thyroid panel including free T3, free T4, reverse T3, TPO antibodies, and thyroglobulin antibodies. Functional TSH target 0.5 to 2.0 mIU/mL. TPO antibody positivity is independently associated with lower implantation rates, poorer embryo quality, and increased miscarriage risk even with normal TSH. TPO antibodies have been detected in follicular fluid.

Gut Health and Microbiome

Not considered part of fertility evaluation.

The gut microbiome regulates immune activity, sex hormone metabolism through the estrobolome, and nutrient absorption. Dysbiosis amplifies autoimmune patterns, disrupts thyroid hormone conversion, and impairs nutrient delivery to developing follicles. GI-MAP stool testing evaluates infections, dysbiosis, and gut barrier integrity. When the gut is dysbiotic, every other intervention in the protocol works less efficiently.

Food Sensitivity and Dietary Inflammation

Not assessed. Diet advice limited to general prenatal nutrition recommendations.

Delayed immune reactions to foods, particularly gluten and dairy, are among the most consistent and addressable contributors to systemic inflammation we see in case reviews. Gluten shares molecular similarities with thyroid tissue and can amplify autoimmune activity through molecular mimicry. Gluten removal for 60 to 90 days alongside food sensitivity testing is part of the protocol for anyone with elevated TPO antibodies or autoimmune history.

Metabolic Status (insulin, blood sugar, vitamin D)

Standard metabolic workup limited to cycle hormone levels. Fasting insulin and vitamin D not routinely checked.

Fasting insulin, hemoglobin A1c, triglycerides, and vitamin D evaluated as an integrated metabolic picture. Vitamin D functional target 60 to 80 ng/mL. Elevated insulin drives systemic inflammatory signaling and oxidative stress that damages mitochondria within developing follicles. Most women supplementing with vitamin D are not reaching levels that meaningfully shift the inflammatory picture.

Adrenal Function and Stress Response

Cortisol and adrenal function not assessed as part of standard fertility evaluation. Stress acknowledged verbally but not investigated clinically.

Chronic HPA axis activation elevates cortisol, drives conversion of active T3 into reverse T3, and suppresses the reproductive signaling pathway governing follicle recruitment and ovulation. Cortisol rhythm testing through the Dried Urine Test for Comprehensive Hormones (DUTCH) evaluates the full adrenal picture. A body in sustained stress de-prioritizes reproduction regardless of what supplements are being taken.

Environmental Toxic Load

Not assessed.

BPA, phthalates, pesticide residues, and heavy metals have been associated with suppressed AMH and disrupted ovarian signaling in published research. Evaluation of environmental chemical burden and detoxification pathway capacity is part of a complete functional fertility assessment. This is almost never investigated in a standard REI workup. Cumulative chemical burden can suppress ovarian signaling over time without producing obvious symptoms.


The 90-Day Preparation Window and Inflammation

Every egg you ovulate or retrieve in an IVF cycle today began developing approximately 90 days ago. That entire maturation window from early follicle recruitment through ovulation or retrieval is shaped by the biological environment your body was in during those three months. Inflammatory load, mitochondrial energy production, nutrient availability, thyroid signaling, gut-hormone communication, and adrenal function all influence the follicle as it develops. The follicle does not exist outside that environment. It develops inside it.

This is the biological basis for why evaluating and addressing inflammation before a cycle matters. Not adjusting the stimulation protocol. Not adding a supplement in the week before retrieval. Genuinely changing the environment those eggs are maturing inside over the full preparation window.

The pattern we see most often in second opinion reviews is multiple IVF cycles with similar outcomes and an inflammatory picture that was never evaluated between them. The clinic adjusted the protocol. The hsCRP was never checked. The thyroid antibodies were never tested. The gut was never assessed. The biological environment proceeded into the next cycle carrying the same load as the previous one. And the outcome reflected that.

The 90-day window is not a guarantee. It is the window in which the work that changes outcomes has to happen. When it is used, the next cycle is not a repeat. It is a genuinely different biological attempt.

Why Your IVF Cycle Was Decided 90 Days Before It Started


Frequently Asked Questions

[DEV: FAQ SCHEMA REQUIRED: FAQPage markup on all questions and answers]

Can inflammation cause infertility?

Chronic low-grade inflammation can disrupt every stage of the reproductive process. It alters hormone signaling through the hypothalamic-pituitary-ovarian axis, impairs follicle development, damages the mitochondria within developing eggs, and creates an immune environment that makes implantation harder to achieve. It is not always obvious there is no fever, no pain. It moves under the surface, showing up in markers like hsCRP that most fertility workups never order. When we see women with low AMH, failed IVF cycles, or unexplained infertility, elevated inflammatory markers are one of the most consistent findings in the picture and one of the most consistently missed.


Can inflammation lower AMH?

AMH reflects how many follicles are currently being recruited into development. Chronic systemic inflammation can suppress follicle recruitment and disrupt the biological environment those follicles develop inside. Thyroid autoimmunity, gut dysbiosis, food sensitivities, metabolic stress, and environmental toxic load have all been associated with reduced ovarian function and lower reserve markers in published research. This does not mean every low AMH is driven by inflammation. It means that accepting a low number without evaluating the inflammatory picture leaves significant questions unanswered.


What is hsCRP and why does it matter for fertility?

High sensitivity C-reactive protein (hsCRP) is a protein produced by the liver in response to inflammation. Unlike standard CRP testing used to detect acute infection or injury, hsCRP detects low-grade chronic inflammation that produces no obvious symptoms but has measurable effects on reproductive outcomes. Research has shown that elevated hsCRP is associated with longer time to conception, poorer IVF outcomes, and increased pregnancy loss risk. The functional fertility target at Fab Fertile is below 1.0 mg/L, with an optimal target below 0.5 mg/L. Most REI clinics do not include hsCRP in their standard workup. It is a straightforward blood draw that can be ordered at most labs and clinics.


Does thyroid autoimmunity affect fertility even with normal TSH?

Yes. TPO antibodies are independently associated with lower implantation rates, poorer embryo quality, and increased miscarriage risk even when TSH is completely normal. TPO antibodies have been detected in follicular fluid, meaning the autoimmune activity reaches the immediate environment surrounding the developing egg. At Fab Fertile our functional TSH target is 0.5 to 2.0 mIU/mL. The standard reference range runs to 4.5 mIU/mL. A woman can sit at TSH 3.5 mIU/mL, be told her thyroid is fine, have elevated TPO antibodies that were never checked, and be experiencing the full impact of thyroid autoimmunity on her fertility picture without anyone having identified it.


How does gut health affect fertility?

The gut microbiome regulates immune activity, sex hormone metabolism, and nutrient absorption three systems that directly shape fertility outcomes. When the gut barrier is compromised, inflammatory signals circulate throughout the body and reach the reproductive system. The estrobolome, the subset of gut bacteria responsible for metabolizing estrogens, is disrupted by dysbiosis, leading to estrogen reabsorption that amplifies autoimmune activity and alters ovarian signaling. Gut bacteria are also responsible for converting a significant portion of inactive thyroid hormone T4 into active T3. When the microbiome is disrupted, thyroid function is affected downstream even when the thyroid gland itself appears normal. We do GI-MAP stool testing to evaluate the full microbial picture because when the gut is dysbiotic, every other intervention in the protocol works less efficiently.


Can inflammation cause recurrent miscarriage?

Chronic inflammation is one of the most consistently missed contributors to recurrent pregnancy loss. Elevated hsCRP, TPO antibodies, antinuclear antibodies (ANA), and food sensitivity-driven immune activation have all been associated with implantation failure and early pregnancy loss. The immune system has to achieve a state of tolerance to allow the embryo to implant and develop. When systemic inflammation is present and unaddressed, that tolerance is harder to achieve. What we see consistently at Fab Fertile: women who have experienced multiple losses and whose inflammatory picture hsCRP, thyroid antibodies, gut infections, food sensitivities was never evaluated before they were told to try again.


How do I reduce inflammation to improve fertility?

The starting point is always testing, not guessing. hsCRP, homocysteine, full thyroid panel including antibodies, ferritin, vitamin D, and a GI-MAP stool test give you the actual picture. From there the protocol is targeted. The elimination diet, removing gluten and dairy for 60 to 90 days alongside food sensitivity testing addresses dietary inflammation systematically. Gut repair addresses dysbiosis and the infections driving immune activation. Stress regulation addresses the HPA axis pattern suppressing reproductive signaling. Targeted supplementation omega-3 fatty acids, vitamin D to a functional target of 60 to 80 ng/mL, CoQ10, magnesium, methylated B vitamins supports mitochondrial function and reduces oxidative stress. These interventions work together and in sequence. Testing first. Then a targeted plan based on what the testing actually shows.



What the Research Shows

The research on inflammation and fertility has been building for years. What is new is not the evidence. It is how consistently it gets ignored in the standard evaluation model.

A 2025 review published in Reproduction confirmed that chronic inflammation has a measurable negative impact on oocyte quality, folliculogenesis, hormone production, and immune signaling in women. The review documented that inflammatory cytokines infiltrate the ovarian environment directly, affecting follicle development and egg competence independent of age and reserve markers.

Research published in Human Reproduction found that women with elevated hsCRP took longer to conceive and had poorer IVF outcomes. Research published in Fertility and Sterility showed that among women with unexplained infertility undergoing ovarian stimulation, higher hsCRP levels were associated with progressively increased pregnancy loss risk a risk ratio of 1.67 at hsCRP between 1 and 3 mg/L, rising to 2.14 at levels above 10 mg/L compared to women below 1 mg/L.

Thyroid autoimmunity is independently associated with lower implantation rates, poorer embryo quality, and increased miscarriage risk in IVF cycles even when TSH is within the standard reference range. A 2025 meta-analysis confirmed that TPO antibodies have been detected in follicular fluid and create a cytotoxic environment that directly impairs oocyte maturation.

A 2024 review in Frontiers in Cellular and Infection Microbiology confirmed that gut dysbiosis influences gonadotropin secretion and estrogen metabolism through neuroendocrine and metabolic pathways. The estrobolome mechanism through which dysbiosis increases estrogen reabsorption and amplifies autoimmune activity is documented, measurable, and addressable. It is not part of a standard fertility workup.

Targeted nutritional supplementation for more than two months before IVF significantly improved high-quality embryo rate and clinical pregnancy rates in women with diminished ovarian reserve across a 2025 meta-analysis of 16 studies and 2,773 participants. CoQ10 had the strongest and most consistent effect. The mechanism is mitochondrial better cellular energy production during the 90-day maturation window in a body where inflammatory load has been reduced enough for that support to work.

Environmental toxin exposure has been associated with suppressed AMH in published research, suggesting that for some women reserve markers reflect cumulative chemical burden rather than irreversible biological aging. (Zhang Y et al. Int J Environ Res Public Health. 2022)


More Stories From the Fab Fertile Community

These are not outliers. They are what becomes possible when the full biological picture is evaluated and addressed not just the AMH number.


Pregnant at 44 with AMH 0.02 ng/mL Samantha's Story

Low AMH and Recurrent Pregnancy Loss

Premature Ovarian Insufficiency at 27 Pregnant Naturally


The Case for a Second Opinion

If you have a low AMH result and your hsCRP has never been checked, your thyroid antibodies have never been tested, your gut has never been evaluated, and your inflammatory picture has never been addressed, you have not yet had a complete workup. You have had a partial one.

That is not a criticism of your clinic. The conventional fertility model is not built to evaluate these systems. It is built around retrieval, stimulation, and transfer. What sits upstream of those mechanics the biological environment shaping whether they produce a viable outcome is a different evaluation that requires a different lens.

The Functional Fertility Second Opinion is where that evaluation happens. Not to replace your clinic. Not to talk you out of any path you are considering. To review what your data is already showing, identify what has not been evaluated, and make sure your next decision is based on the full picture rather than a partial one.

In most of the cases we review at Fab Fertile, the AMH number was real. The reserve was genuinely reduced. But the inflammatory systems influencing that reserve had never been looked at. And when they were, there were things to work with that changed the direction of the conversation entirely.

If you are preparing for another cycle and the biological environment has not changed since the last one, the next cycle is not a new attempt. It is a repeat. That is what the Functional Fertility Second Opinion is designed to interrupt.


Book a Functional Fertility Second Opinion

Download the Embryo Audit Checklist


Related Content

Low AMH: What the Number Signals and What It Does Not

DOR: Interpreting Capacity Versus Potential

High FSH: What the Number Is Actually Telling You

Repeated IVF Failure: What Your Cycles Are Telling You

Embryo Arrest: What the Pattern Indicates

Male Factor Fertility: The Overlooked Variable

Recurrent Pregnancy Loss: When Implantation Occurs But Stability Fails

Unexplained Infertility: What That Label Actually Means


Sources and Research

Chronic inflammation and female fertility. Reproduction. 2025

Hashimoto's Thyroiditis and Female Fertility. PMC. 2025

ASRM. Subclinical hypothyroidism in the infertile female population: a guideline. 2024

Zhang Y et al. Environmental toxin exposure and diminished ovarian reserve markers. Int J Environ Res Public Health. 2022.

Wang M et al. The gut microbiota: emerging biomarkers and potential treatments for infertility-related diseases. Front Cell Infect Microbiol. 2024

Oral nutritional supplements and diminished ovarian reserve: meta-analysis of 16 studies, 2773 participants. PMC. 2025

Vitamin D supplementation improves embryo quality in IVF. Arch Gynecol Obstet. 2024

Knezevic J et al. Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? Nutrients. 2020.

IFM. The Inflammatory Response and Reproductive Health. 

Reviewed by Dr. Labib Ghulmiyyah, MD

Board Certified in Obstetrics and Gynecology
Board Certified in Maternal Fetal Medicine
Certified in Functional Medicine

This content has been reviewed for alignment with the Fab Fertile clinical framework. The biological patterns and systems-based interpretations discussed in this article reflect the methodology used in Functional Fertility Second Opinion case reviews.

Dr. Labib contributes physician-level perspective to the Fab Fertile clinical framework in an advisory capacity. Clients remain under the care of their own treating physicians for all medical decisions.

Connect with Dr. Labib on LinkedIn

CURRENT VERSION VERIFIED APRIL 2026

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking care because of something you have read on this website.